Marilena Celano Selected Research

oleuropein

4/2020	Oleacein inhibits STAT3, activates the apoptotic machinery, and exerts anti-metastatic effects in the SH-SY5Y human neuroblastoma cells.
1/2015	Oral Administration of Oleuropein and Its Semisynthetic Peracetylated Derivative Prevents Hepatic Steatosis, Hyperinsulinemia, and Weight Gain in Mice Fed with High Fat Cafeteria Diet.
8/2014	Beneficial effects of the olive oil phenolic components oleuropein and hydroxytyrosol: focus on protection against cardiovascular and metabolic diseases.
1/2013	Antioxidant and antigrowth action of peracetylated oleuropein in thyroid cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marilena Celano Research Topics

Disease

18	Neoplasms (Cancer) 04/2022 - 09/2004
17	Thyroid Neoplasms (Thyroid Cancer) 04/2022 - 09/2004
7	Anaplastic Thyroid Carcinoma 09/2021 - 09/2004
6	Papillary Thyroid Cancer 04/2022 - 03/2009
4	Insulin Resistance 01/2019 - 01/2015
2	Neuroblastoma 04/2020 - 11/2010
2	Weight Gain 01/2018 - 01/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 01/2015
2	Body Weight (Weight, Body) 01/2018 - 01/2016
1	Lymphatic Metastasis 01/2022
1	Triple Negative Breast Neoplasms 12/2019
1	Glucose Intolerance 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Obesity 01/2019
1	Fatty Liver 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Hyperinsulinism (Hyperinsulinemia) 01/2015
1	Metabolic Diseases (Metabolic Disease) 08/2014
1	Follicular Adenocarcinoma 08/2014
1	Adenoma (Adenomas) 02/2013
1	Thyroid Nodule (Nodule, Thyroid) 02/2013
1	Carcinogenesis 11/2010
1	Adenocarcinoma 04/2010
1	Prostatic Neoplasms (Prostate Cancer) 04/2010
1	Carcinoma (Carcinomatosis) 09/2004
1	Inappropriate ADH Syndrome (SIADH) 06/2002
1	Hyponatremia 06/2002
1	Vomiting 06/2002
1	Nausea 06/2002

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 12/2019 - 04/2010
5	Pharmaceutical PreparationsIBA 01/2018 - 09/2004
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2010
4	oleuropeinIBA 04/2020 - 01/2013
4	Messenger RNA (mRNA)IBA 01/2019 - 04/2014
3	MicroRNAs (MicroRNA)IBA 04/2022 - 01/2017
3	oleaceinIBA 04/2020 - 01/2018
3	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019 - 01/2017
3	Olive OilIBA 01/2019 - 08/2014
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2015
3	Thyrotropin Receptors (Thyrotropin Receptor)IBA 11/2015 - 02/2013
3	Gemcitabine FDA Link 08/2014 - 09/2004
3	sodium-iodide symporter (sodium iodide symporter)IBA 04/2014 - 07/2005
2	IodineIBA 01/2021 - 01/2020
2	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 04/2020 - 08/2014
2	Insulin (Novolin)FDA Link 01/2018 - 01/2016
2	Sildenafil Citrate (Viagra)FDA Link 05/2016 - 11/2015
2	Tadalafil (Cialis)FDA Link 05/2016 - 11/2015
1	Cisplatin (Platino)FDA LinkGeneric 09/2021
1	PhytochemicalsIBA 01/2021
1	QuercetinIBA 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	(+)-JQ1 compoundIBA 12/2019
1	AdipokinesIBA 01/2019
1	molibresibIBA 01/2019
1	lenvatinibIBA 01/2019
1	Leptin ReceptorsIBA 01/2019
1	Protein Kinase InhibitorsIBA 01/2019
1	IridoidsIBA 01/2019
1	ParaffinIBA 01/2019
1	cynaropicrinIBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	LeptinIBA 01/2019
1	CholesterolIBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Histones (Histone)IBA 01/2018
1	LipidsIBA 01/2018
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 05/2016
1	Thyroglobulin FDA Link 11/2015
1	Phosphodiesterase 5 InhibitorsIBA 11/2015
1	LDL CholesterolIBA 01/2015
1	FlavonoidsIBA 01/2015
1	RacivirIBA 04/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2013
1	Hormones (Hormone)IBA 02/2013
1	Saline SolutionIBA 02/2013
1	platelet-derived growth factor AIBA 02/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2013
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 02/2013
1	NanocapsulesIBA 02/2013
1	Biological ProductsIBA 01/2013
1	AntioxidantsIBA 01/2013
1	Sunitinib (Sutent)FDA Link 02/2012
1	Phosphotransferases (Kinase)IBA 02/2012
1	pyrimidineIBA 11/2010
1	src-Family KinasesIBA 11/2010
1	ProhibitinsIBA 03/2009
1	IodidesIBA 07/2005
1	Antineoplastic Agents (Antineoplastics)IBA 09/2004
1	Liposomes (Liposome)IBA 09/2004
1	Vasopressins (Vasopressin)IBA 06/2002
1	SodiumIBA 06/2002

Therapy/Procedure

3	Therapeutics 01/2018 - 09/2004
2	Mediterranean Diet 01/2018 - 01/2015
2	Oral Administration 01/2018 - 01/2015
1	Intravenous Administration 01/2018